🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this randomized study is to determine the safety and efficac...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2021-09-03
Trial ID
NCT04486833
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a nonrandomized, open phase I dose escalation and extension clinica...
Status
Unknown
Location
Zhangli
Start Date
2022-09-21
Trial ID
NCT05489731
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234
This study will assess the safety and efficacy of Osimertinib with Amivanta...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-07-18
Trial ID
NCT05801029
Treatments Being Tested
Osimertinib combined with savolitinib in the treatment of EGFR mutated osim...
Status
Recruiting
Location
Qingdao Central Hospital
Start Date
2025-01-01
Trial ID
NCT07322783
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-04
Trial ID
NCT02197247
This study is to evaluate the efficacy and safety of TY-9591 in first-line ...
Status
Recruiting
Location
National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-08-17
Trial ID
NCT05948813
Treatments Being Tested
Clinical study to investigate the efficacy and safety of savolitinib in com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-08-03
Trial ID
NCT05261399
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Shanxi Cancer hospital
Start Date
2025-03-28
Trial ID
NCT06895928